Skip Navigation



ToxSci Advance Access published online on December 29, 2005

Toxicological Sciences, doi:10.1093/toxsci/kfj088
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
90/2/419    most recent
kfj088v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kharasch, E. D.
Right arrow Articles by Srinouanprachanh, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kharasch, E. D.
Right arrow Articles by Srinouanprachanh, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received October 19, 2005
Accepted December 25, 2005

Genetic Toxicology

Gene Expression Profiling of Nephrotoxicity from the Sevoflurane Degradation Product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in Rats

Evan D. Kharasch MD PhD 1 *, Jesara L. Schroeder BS 2, Theo Bammler PhD 3, Richard Beyer PhD 3, and Sengkeo Srinouanprachanh BS 3

1 Department of Anesthesiology; Washington University, 660 S Euclid Ave, Campus Box 8054, St. Louis, MO 63110-1093
2 Department of Anesthesiology; University of Washington, Box 356540, Seattle, WA 98195
3 Department of Environmental Health, University of Washington, Box 354695

* To whom correspondence should be addressed.
Evan D. Kharasch, E-mail: kharasch{at}wustl.edu


   Abstract

The major degradation product of the volatile anesthetic sevoflurane, the haloalkene fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (FDVE or "compound A"), is nephrotoxic in rats. FDVE undergoes complex metabolism and bioactivation which mediates the nephrotoxicity. Nevertheless, the molecular and cellular mechanisms of FDVE toxification are unknown. This investigation evaluated the gene expression profile of kidneys in rats administered a nephrotoxic dose of FDVE. Male Fischer 344 rats (5 per group) received 0.25 mmol/kg intraperitoneal FDVE or corn oil (controls) and were sacrificed after 24 or 72 hr. Urine output and kidney histological changes were quantified. Kidney RNA was extracted for microarray analysis using Affymetrix GeneChip® Rat Expression Array 230A arrays. Quantitative real-time PCR confirmed the modulation of several genes. FDVE caused significant diuresis and necrosis at 24 hr, with normal urine output and evidence of tubular regeneration at 72 hr. There were 517 informative genes that were differentially expressed >1.5-fold (p<0.05) vs control at 24 hr, of which 283 and 234 were upregulated and downregulated, respectively. Major classes of upregulated genes included those involved in apoptosis, oxidative stress, and inflammatory response (mostly at 24 hr), and regeneration and repair; downregulated genes were generally associated with transporters and intermediary metabolism. Among the quantitatively most upregulated genes were kidney injury molecule, osteopontin, clusterin, tissue inhibitor of metalloproteinase 1, and TNF receptor 12, which have been associated with other forms of nephrotoxicity, and angiopoietin-like protein 4, glycoprotein nmb, ubiquitin hydrolase, and HSP70. Microarray results were confirmed by quantitative real-time PCR. FDVE causes rapid and brisk changes in gene expression, providing potential insights into the mechanism of FDVE toxification, and potential biomarkers for FDVE nephrotoxicity which are more sensitive than conventional measures of renal function.

Keywords: sevoflurane; compound A; nephrotoxicity; haloalkene; microarray; kidney injury molecule.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
M. Sieber, D. Hoffmann, M. Adler, V. S. Vaidya, M. Clement, J. V. Bonventre, N. Zidek, E. Rached, A. Amberg, J. J. Callanan, et al.
Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity
Toxicol. Sci., June 1, 2009; 109(2): 336 - 349.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Dieterich, A. Puey, S. Lyn, R. Swezey, A. Furimsky, D. Fairchild, J. C. Mirsalis, and H. H. Ng
Gene Expression Analysis Reveals New Possible Mechanisms of Vancomycin-Induced Nephrotoxicity and Identifies Gene Markers Candidates
Toxicol. Sci., January 1, 2009; 107(1): 258 - 269.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Rached, D. Hoffmann, K. Blumbach, K. Weber, W. Dekant, and A. Mally
Evaluation of Putative Biomarkers of Nephrotoxicity after Exposure to Ochratoxin A In Vivo and In Vitro
Toxicol. Sci., June 1, 2008; 103(2): 371 - 381.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.